Furthermore, Galos et al. reported that intravenous administration of lidocaine during breast cancer surgery resulted in reduced postoperative expression of extracellular neutrophil traps (NETosis) and matrix metalloproteinase 3 (MMP3), potentially contributing to a decrease in disease recurrence [82]. Here, MMP3 is linked to breast carcinoma.